| Zaman aralığı | Tahmini Fiyat | Geçmiş | Tarihsel | İç yüzü |
|---|---|---|---|---|
| Yarın | $3.61 ▲ +1.33% | Dün | $3.54 ▼ -0.56% | Tomorrow's Recursion Pharmaceuticals Inc. Class A Common Stock (RXRX) setup is anchored to $3.56 and targets $3.61 (+1.33%). The near-term read is upside; watch $3.67 / $3.45 because daily realized volatility is about 6.84%. |
Tomorrow's Recursion Pharmaceuticals Inc. Class A Common Stock (RXRX) setup is anchored to $3.56 and targets $3.61 (+1.33%). The near-term read is upside; watch $3.67 / $3.45 because daily realized volatility is about 6.84%. | ||||
| Hafta | $3.71 ▲ +4.12% | Geçen hafta | $3.50 ▼ -1.73% | The 7-day Recursion Pharmaceuticals Inc. Class A Common Stock model moves from $3.50 to $3.71 (+4.12%). It gives upside momentum context for this stock, so breaks around $3.67 / $3.45 matter more than a single tick. |
The 7-day Recursion Pharmaceuticals Inc. Class A Common Stock model moves from $3.50 to $3.71 (+4.12%). It gives upside momentum context for this stock, so breaks around $3.67 / $3.45 matter more than a single tick. | ||||
| Ay | $3.87 ▲ +8.79% | Geçen ay | $3.43 ▼ -3.69% | The 1-month Recursion Pharmaceuticals Inc. Class A Common Stock target is $3.87 (+8.79%), compared with the live reference near $3.56. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Recursion Pharmaceuticals Inc. Class A Common Stock target is $3.87 (+8.79%), compared with the live reference near $3.56. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Yıl | $4.12 ▲ +15.77% | Geçen sene | $3.32 ▼ -6.62% | The 1-year Recursion Pharmaceuticals Inc. Class A Common Stock scenario points to $4.12 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Recursion Pharmaceuticals Inc. Class A Common Stock scenario points to $4.12 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Yıl | $4.70 ▲ +32.14% | 5 Yıl Önce | $3.08 ▼ -13.50% | The 5-year Recursion Pharmaceuticals Inc. Class A Common Stock view is $4.70 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Recursion Pharmaceuticals Inc. Class A Common Stock view is $4.70 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Gösterge | Değer | Sinyal |
|---|---|---|
| Price | $3.56 | Mid |
| Daily Change | -3.52% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 65% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $3.56 | Daily Change | -3.52% |
| Market Cap | $1.88B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.